Shelter Pharma Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q4 FY26 earnings call
Shelter Pharma reported FY26 revenue from operations of Rs 73.13 crore, up 44% year-on-year, with EBITDA of Rs 12.72 crore and PAT of Rs 9.03 crore. Management said exports grew 164% to around Rs 6 crore and that veterinary contributed 55% of revenue against 45% from human healthcare. The company outlined plans for a second manufacturing facility near Ahmedabad and set a long-term revenue target of around Rs 200 crore by FY2030.